中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 40 Issue 6
Jun.  2024
Turn off MathJax
Article Contents

Association between hypertension and the risk of gallstone disease

DOI: 10.12449/JCH240623
Research funding:

National Natural Science Foundation of China (81903398);

Fundamental Research Funds for the Central Universities (YJ2021112);

Young Innovative Subjects for Medical Research of Sichuan Medical Association (Q21016);

Young Talent Project of Sichuan Tianfu Emei Program (Sichuan Emei 1841);

Outstanding Young Science Foundation of Sichuan Provincial Science and Technology Department (2023NSFSC1927)

More Information
  • Corresponding author: WANG Xin, wangxinmarine@126.com (ORCID: 0000-0001-9325-3194)
  • Received Date: 2023-11-02
  • Accepted Date: 2024-01-02
  • Published Date: 2024-06-25
  •   Objective  This article aims to investigate the association between hypertension and the risk of GSD by conducting a national multicenter study, a systematic review, and a meta-analysis.  Methods  The study was conducted in three stages. In the first stage, subjects were recruited for health examination in four hospitals in Chengdu, Tianjin, Beijing, and Chongqing, China, from 2015 to 2020, and the multivariate logistic regression analysis was used to investigate the association between hypertension and the risk of GSD in each center. In the second stage, Embase, PubMed, Wanfang Data, VIP, and CNKI databases were searched for related studies published up to May 2021, and a meta-analysis was conducted to further verify such association. In the third stage, the random effects model was used for pooled analysis of the results of the multicenter cross-sectional study and the findings of previous literature.  Results  A total of 633 948 participants were enrolled in the cross-sectional study, and the prevalence rate of GSD was 7.844%. The multivariate logistic regression analysis showed that hypertension was positively associated with the risk of GSD(P<0.05). Subgroup analysis showed that there was no significant difference in the association between hypertension and GSD between individuals with different sexes, ages, and subtypes of GSD. A total of 80 articles were included in the systematic review and the meta-analysis, and the results showed that the risk of GSD was increased by 1.022 times for every 10 mmHg increase in diastolic pressure and 1.014 times for every 10 mmHg increase in systolic pressure.  Conclusion  Hypertension significantly increases the risk of GSD, and the findings of this study will provide a basis for the etiology of GSD and the identification of high-risk groups.

     

  • loading
  • [1]
    LAMMERT F, GURUSAMY K, KO CW, et al. Gallstones[J]. Nat Rev Dis Primers, 2016, 2: 16024. DOI: 10.1038/nrdp.2016.24.
    [2]
    PORTINCASA P, MOSCHETTA A, PALASCIANO G. Cholesterol gallstone disease[J]. Lancet, 2006, 368( 9531): 230- 239. DOI: 10.1016/s0140-6736(06)69044-2.
    [3]
    SONG ST, SHI J, WANG XH, et al. Prevalence and risk factors for gallstone disease: A population-based cross-sectional study[J]. J Dig Dis, 2020, 21( 4): 237- 245. DOI: 10.1111/1751-2980.12857.
    [4]
    WANG F, WANG J, LI YR, et al. Gallstone disease and type 2 diabetes risk: A Mendelian randomization study[J]. Hepatology, 2019, 70( 2): 610- 620. DOI: 10.1002/hep.30403.
    [5]
    PANG YJ, LV J, KARTSONAKI C, et al. Causal effects of gallstone disease on risk of gastrointestinal cancer in Chinese[J]. Br J Cancer, 2021, 124( 11): 1864- 1872. DOI: 10.1038/s41416-021-01325-w.
    [6]
    SHABANZADEH DM, SKAABY T, SØRENSEN LT, et al. Screen-detected gallstone disease and cardiovascular disease[J]. Eur J Epidemiol, 2017, 32( 6): 501- 510. DOI: 10.1007/s10654-017-0263-x.
    [7]
    SHABANZADEH DM, SØRENSEN LT, JØRGENSEN T. Gallstone disease and mortality: A cohort study[J]. Int J Public Health, 2017, 62( 3): 353- 360. DOI: 10.1007/s00038-016-0916-7.
    [8]
    SHABANZADEH DM. Incidence of gallstone disease and complications[J]. Curr Opin Gastroenterol, 2018, 34( 2): 81- 89. DOI: 10.1097/MOG.0000000000000418.
    [9]
    SHAFFER EA. Gallstone disease: Epidemiology of gallbladder stone disease[J]. Best Pract Res Clin Gastroenterol, 2006, 20( 6): 981- 996. DOI: 10.1016/j.bpg.2006.05.004.
    [10]
    LIN IC, YANG YW, WU MF, et al. The association of metabolic syndrome and its factors with gallstone disease[J]. BMC Fam Pract, 2014, 15: 138. DOI: 10.1186/1471-2296-15-138.
    [11]
    HUNG MC, CHEN CF, TSOU MT, et al. Relationship between gallstone disease and cardiometabolic risk factors in elderly people with non-alcoholic fatty liver disease[J]. Diabetes Metab Syndr Obes, 2020, 13: 3579- 3585. DOI: 10.2147/DMSO.S266947.
    [12]
    ALMOBARAK AO, JERVASE A, FADL AA, et al. The prevalence of diabetes and metabolic syndrome and associated risk factors in Sudanese individuals with gallstones: A cross sectional survey[J]. Transl Gastroenterol Hepatol, 2020, 5: 14. DOI: 10.21037/tgh.2019.10.09.
    [13]
    CHANG Y, NOH YH, SUH BS, et al. Bidirectional association between nonalcoholic fatty liver disease and gallstone disease: A cohort study[J]. J Clin Med, 2018, 7( 11): 458. DOI: 10.3390/jcm7110458.
    [14]
    WANIEK S, DI GIUSEPPE R, ESATBEYOGLU T, et al. Association of circulating vitamin E(α- and γ-tocopherol) levels with gallstone disease[J]. Nutrients, 2018, 10( 2): 133. DOI: 10.3390/nu10020133.
    [15]
    WANG JW, SHEN S, WANG B, et al. Serum lipid levels are the risk factors of gallbladder stones: A population-based study in China[J]. Lipids Health Dis, 2020, 19( 1): 50. DOI: 10.1186/s12944-019-1184-3.
    [16]
    WALCHER T, HAENLE MM, KRON M, et al. Vitamin C supplement use may protect against gallstones: An observational study on a randomly selected population[J]. BMC Gastroenterol, 2009, 9: 74. DOI: 10.1186/1471-230X-9-74.
    [17]
    STROUP DF, BERLIN JA, MORTON SC, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology(MOOSE) group[J]. JAMA, 2000, 283( 15): 2008- 2012. DOI: 10.1001/jama.283.15.2008.
    [18]
    HIGGINS JPT, THOMPSON SG. Quantifying heterogeneity in a meta-analysis[J]. Stat Med, 2002, 21( 11): 1539- 1558. DOI: 10.1002/sim.1186.
    [19]
    BROK J, THORLUND K, GLUUD C, et al. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses[J]. J Clin Epidemiol, 2008, 61( 8): 763- 769. DOI: 10.1016/j.jclinepi.2007.10.007.
    [20]
    GONZÁLEZ-PÉREZ A, GARCÍA RODRÍGUEZ LA. Gallbladder disease in the general population: Association with cardiovascular morbidity and therapy[J]. Pharmacoepidemiol Drug Saf, 2007, 16( 5): 524- 531. DOI: 10.1002/pds.1346.
    [21]
    CHATTERJEE S, WETTERSLEV J, SHARMA A, et al. Association of blood transfusion with increased mortality in myocardial infarction: A meta-analysis and diversity-adjusted study sequential analysis[J]. JAMA Intern Med, 2013, 173( 2): 132- 139. DOI: 10.1001/2013.jamainternmed.1001.
    [22]
    BOLAND LL, FOLSOM AR, ROSAMOND WD, et al. Hyperinsulinemia, dyslipidemia, and obesity as risk factors for hospitalized gallbladder disease. A prospective study[J]. Ann Epidemiol, 2002, 12( 2): 131- 140. DOI: 10.1016/s1047-2797(01)00260-5.
    [23]
    WEI W, LI Y, CHEN F, et al. Dyslipidaemia, combined oral contraceptives use and their interaction on the risk of hypertension in Chinese women[J]. J Hum Hypertens, 2011, 25( 6): 364- 371. DOI: 10.1038/jhh.2010.67.
    [24]
    HAN TS, LAN L, QU RG, et al. Temporal relationship between hyperuricemia and insulin resistance and its impact on future risk of hypertension[J]. Hypertension, 2017, 70( 4): 703- 711. DOI: 10.1161/HYPERTENSIONAHA.117.09508.
    [25]
    WANG F, HAN LL, HU DY. Fasting insulin, insulin resistance and risk of hypertension in the general population: A meta-analysis[J]. Clin Chim Acta, 2017, 464: 57- 63. DOI: 10.1016/j.cca.2016.11.009.
    [26]
    CORTÉS VA, BARRERA F, NERVI F. Pathophysiological connections between gallstone disease, insulin resistance, and obesity[J]. Obes Rev, 2020, 21( 4): e12983. DOI: 10.1111/obr.12983.
    [27]
    JANOWITZ P, WECHSLER JG, KUHN K, et al. The relationship between serum lipids, nucleation time, and biliary lipids in patients with gallstones[J]. Clin Investig, 1992, 70( 5): 430- 436. DOI: 10.1007/BF00235527.
    [28]
    SCRAGG RK, CALVERT GD, OLIVER JR. Plasma lipids and insulin in gall stone disease: A case-control study[J]. Br Med J(Clin Res Ed), 1984, 289( 6444): 521- 525. DOI: 10.1136/bmj.289.6444.521.
    [29]
    HUSSAINI SH, PEREIRA SP, MURPHY GM, et al. Deoxycholic acid influences cholesterol solubilization and microcrystal nucleation time in gallbladder bile[J]. Hepatology, 1995, 22( 6): 1735- 1744.
    [30]
    RUHL CE, EVERHART JE. Association of diabetes, serum insulin, and C-peptide with gallbladder disease[J]. Hepatology, 2000, 31( 2): 299- 303. DOI: 10.1002/hep.510310206.
    [31]
    SHANKAR A, XIAO J. Positive relationship between plasma leptin level and hypertension[J]. Hypertension, 2010, 56( 4): 623- 628. DOI: 10.1161/HYPERTENSIONAHA.109.148213.
    [32]
    SARAÇ S, ATAMER A, ATAMER Y, et al. Leptin levels and lipoprotein profiles in patients with cholelithiasis[J]. J Int Med Res, 2015, 43( 3): 385- 392. DOI: 10.1177/0300060514561134.
    [33]
    ZHANG YY, CHUA S Jr. Leptin function and regulation[J]. Compr Physiol, 2017, 8( 1): 351- 369. DOI: 10.1002/cphy.c160041.
    [34]
    WANG SN, YEH YT, YU ML, et al. Hyperleptinaemia and hypoadiponectinaemia are associated with gallstone disease[J]. Eur J Clin Invest, 2006, 36( 3): 176- 180. DOI: 10.1111/j.1365-2362.2006.01611.x.
    [35]
    KAZE AD, MUSANI SK, BIDULESCU A, et al. Plasma leptin and blood pressure progression in blacks: The Jackson heart study[J]. Hypertension, 2021, 77( 4): 1069- 1075. DOI: 10.1161/HYPERTENSIONAHA.120.16174.
    [36]
    ROY S, HYOGO H, YADAV SK, et al. A biphasic response of hepatobiliary cholesterol metabolism to dietary fat at the onset of obesity in the mouse[J]. Hepatology, 2005, 41( 4): 887- 895. DOI: 10.1002/hep.20643.
    [37]
    HYOGO H, ROY S, PAIGEN B, et al. Leptin promotes biliary cholesterol elimination during weight loss in ob/ob mice by regulating the enterohepatic circulation of bile salts[J]. J Biol Chem, 2002, 277( 37): 34117- 34124. DOI: 10.1074/jbc.M203912200.
    [38]
    VANPATTEN S, RANGINANI N, SHEFER S, et al. Impaired biliary lipid secretion in obese Zucker rats: Leptin promotes hepatic cholesterol clearance[J]. Am J Physiol Gastrointest Liver Physiol, 2001, 281( 2): G393- G404. DOI: 10.1152/ajpgi.2001.281.2.G393.
    [39]
    CHOOI YC, DING C, MAGKOS F. The epidemiology of obesity[J]. Metabolism, 2019, 92: 6- 10. DOI: 10.1016/j.metabol.2018.09.005.
    [40]
    FRANKLIN SS, 4th GUSTIN W, WONG ND, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study[J]. Circulation, 1997, 96( 1): 308- 315. DOI: 10.1161/01.cir.96.1.308.
    [41]
    WANG HH, LIU M, CLEGG DJ, et al. New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation[J]. Biochim Biophys Acta, 2009, 1791( 11): 1037- 1047. DOI: 10.1016/j.bbalip.2009.06.006.
    [42]
    SHABANZADEH DM, SØRENSEN LT, JØRGENSEN T. Determinants for gallstone formation- a new data cohort study and a systematic review with meta-analysis[J]. Scand J Gastroenterol, 2016, 51( 10): 1239- 1248. DOI: 10.1080/00365521.2016.1182583.
    [43]
    ZHANG C, HU SL, SUN P, et al. Prevalence of gallstones among university teachers and related risk factors: A multicenter study[J]. J Clin Hepatol, 2020, 36( 3): 624- 630. DOI: 10.3969/j.issn.1001-5256.2020.03.031.

    张弛, 胡舒铃, 孙鹏, 等. 大学教师胆结石患病现状及危险因素的多中心研究[J]. 临床肝胆病杂志, 2020, 36( 3): 624- 630. DOI: 10.3969/j.issn.1001-5256.2020.03.031.
    [44]
    GRÜNHAGE F, ACALOVSCHI M, TIRZIU S, et al. Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol[J]. Hepatology, 2007, 46( 3): 793- 801. DOI: 10.1002/hep.21847.
    [45]
    STENDER S, FRIKKE-SCHMIDT R, NORDESTGAARD BG, et al. The ABCG5/8 cholesterol transporter and myocardial infarction versus gallstone disease[J]. J Am Coll Cardiol, 2014, 63( 20): 2121- 2128. DOI: 10.1016/j.jacc.2013.12.055.
    [46]
    HUESCA-GÓMEZ C, TORRES-PAZ YE, MARTÍNEZ-ALVARADO R, et al. Association between the transporters ABCA1/G1 and the expression of miR-33a/144 and the carotid intima media thickness in patients with arterial hypertension[J]. Mol Biol Rep, 2020, 47( 2): 1321- 1329. DOI: 10.1007/s11033-019-05229-0.
    [47]
    ZHANG N, JIA J, DING QJ, et al. Common variant rs11191548 near the CYP17A1 gene is associated with hypertension and the serum 25(OH) D levels in Han Chinese[J]. J Hum Genet, 2018, 63( 6): 731- 737. DOI: 10.1038/s10038-018-0435-x.
    [48]
    ZHANG N, CHEN HM, JIA J, et al. The CYP17A1 gene polymorphisms are associated with hypercholesterolemia in Han Chinese[J]. J Gene Med, 2019, 21( 8): e3102. DOI: 10.1002/jgm.3102.
    [49]
    PUPPALA S, DODD GD, FOWLER S, et al. A genomewide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans[J]. Am J Hum Genet, 2006, 78( 3): 377- 392. DOI: 10.1086/500274.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(3)  / Tables(3)

    Article Metrics

    Article views (296) PDF downloads(37) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return